Skip to main content

India patent regime not about access to medicine: U.S body

In an indirect jab at India’s support towards generic drug-makers, GIPC of the chamber of commerce has pointed out that in many cases, multi-national drug-makers would give away the drug for free. File photo.
AP In an indirect jab at India’s support towards generic drug-makers, GIPC of the chamber of commerce has pointed out that in many cases, multi-national drug-makers would give away the drug for free. File photo.

With U.S Trade Representative Michael Froman set to announce a trade enforcement action tied to India, the highly influential U.S Chamber of Commerce has lashed out at India’s recent pattern of pharma patent denials, pointing out that the country’s actions “are not about access to medicine.”
In the case of Swiss drug-maker Novartis, whose cancer drug’s patent protections were dismissed by the Supreme Court, the chamber has argued that the patent revocation led to the drug actually becoming “more expensive for Indian patients.”
The chamber’s argument is part of a set of recent recommendations, which were submitted to the office of the U.S trade representative (UTSR). The recommendations are being by trade experts as a pointer to what sectors the USTR’s expected trade enforcement actions could affect.
In an indirect jab at India’s support towards generic drug-makers, the Global Intellectual Property Centre (GIPC) of the chamber of commerce has pointed out that in many cases, multi-national drug-makers would give away the drug for free.
“In the case of Glivec, Novartis provided the leukaemia drug to 95 per cent of patient population for free. The annual cost for Glivec generic treatment is approximately three to for times the average annual income in India,” the chamber said.
Thus, the chamber points out, it is actually “more expensive for Indian patents to obtain access to these medicines after the patent revocation than it was before”.
In its submission, the chamber has also asked that India be classified as a ‘priority foreign country’— a tag that is generally given to the worst intellectual property offenders, and is also a classification that could trigger trade sanctions.
It also warns of a possible domino effect, with other countries following India as an example of bad behaviour.
“India’s policies are clearly discriminatory, in contravention to their obligations under TRIPS (The Agreement on Trade Related Aspects of Intellectual Property Rights). In addition, other countries such as South Africa, Brazil, Argentina and even China are closely monitoring this new Indian IP model.”
Labels:

Comments

Post a Comment

Popular posts from this blog

NGT terminates chairmen of pollution control boards in 10 states (downtoearth,)

Cracking the whip on 10 State Pollution Control Boards (SPCBs) for ad-hoc appointments, the National Green Tribunal has ordered the termination of Chairpersons of these regulatory authorities. The concerned states are Himachal Pradesh, Sikkim, Tamil Nadu, Uttarakhand, Kerala, Rajasthan, Telangana, Haryana, Maharashtra and Manipur. The order was given last week by the principal bench of the NGT, chaired by Justice Swatanter Kumar. The recent order of June 8, 2017, comes as a follow-up to an NGT judgment given in August 2016. In that judgment, the NGT had issued directions on appointments of Chairmen and Member Secretaries of the SPCBs, emphasising on crucial roles they have in pollution control and abatement. It then specified required qualifications as well as tenure of the authorities. States were required to act on the orders within three months and frame Rules for appointment [See Box: Highlights of the NGT judgment of 2016 on criteria for SPCB chairperson appointment]. Having ...
Post a Comment
Click Here To Read more »

High dose of Vitamin C and B3 can kill colon cancer cells: study (downtoearth)

In a first, a team of researchers has found that high doses of Vitamin C and niacin or Vitamin B3 can kill cancer stem cells. A study published in Cell Biology International showed the opposing effects of low and high dose of vitamin C and vitamin B3 on colon cancer stem cells. Led by Bipasha Bose and Sudheer Shenoy, the team found that while low doses (5-25 micromolar) of Vitamin C and B3 proliferate colon cancer stem cells, high doses (100 to 1,000 micromolar) killed cancer stem cells. Such high doses of vitamins can only be achieved through intravenous injections in colon cancer patients. The third leading cause of cancer deaths worldwide, colon cancer can be prevented by an intake of dietary fibre and lifestyle changes. While the next step of the researchers is to delineate the mechanisms involved in such opposing effects, they also hope to establish a therapeutic dose of Vitamin C and B3 for colon cancer stem cell therapy. “If the therapeutic dose gets validated under in vivo...
1 comment
Click Here To Read more »

What's ailing Namami Gange programme?(DTE)

Winters are extremely hectic for Sushma Patel, a vegetable grower in Uttar Pradesh’s Chunar town. Her farm is in the fertile plains of Ganga where people grow three crops a year. But this is the only season when she can grow vegetables. And before that, she needs to manually dig out shreds of plastic and wrappers from her one-hectare (ha) farm. “This is all because of the nullah,” she says, pointing at an open drain that runs through her field, carrying sewage from the neighbourhood to the Ganga. “Every monsoon, the drain overflows and inundates the field with a thick, black sludge and plastic debris. We cannot even go near the field as the stench of sewage fills the air,” she says. But Patel has no one to complain to as this is the way of life for most people in this ancient town. About 70 per cent of the people in Chunar depend on toilets that have on-site sanitation, such as septic tanks and pits. In the absence of a proper disposal or management system, people simply dump the faec...
2 comments
Click Here To Read more »